Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 9Observational 2Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all
NCT07036978 2026-04-15

Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer

Chang Gung Memorial Hospital

Not yet recruiting
140 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06147154 2023-11-30

Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients

Qilu Hospital of Shandong University

Completed
23 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡